AllianceBernstein
INMB icon

AllianceBernstein’s INmune Bio INMB Stock Holding History

AllianceBernstein’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.2K Hold
21,950
– – ﹤0.01% 3211
2025
Q4 		$34.2K Hold
21,950
– – ﹤0.01% 3220
2025
Q3 		$45.4K Hold
21,950
– – ﹤0.01% 3222
2025
Q2 		$50.7K Buy
+21,950
New +$161K ﹤0.01% 3209

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AllianceBernstein's INMB Position: Q1 2026 in Review

AllianceBernstein held its INmune Bio (INMB) position steady in Q1 2026 at 21,950 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

AllianceBernstein first reported a position in INMB in Q2 2025 and has held it in 4 quarters since. The position peaked at $50.7K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • AllianceBernstein held 21,950 shares of INmune Bio worth $34.2K as of Q1 2026.
  • AllianceBernstein left its INmune Bio share count unchanged in Q1 2026.
  • INmune Bio made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3211 holding.
  • AllianceBernstein first reported a position in INmune Bio in Q2 2025 and has held it in 4 quarters since.
  • AllianceBernstein's INmune Bio position peaked at $50.7K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.